2025-2034 Veterinary Renal Disease Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Veterinary Renal Disease Market Through 2025?
In recent times, the market size for veterinary renal disease has seen a significant escalation. The market which is projected to be worth $15.5 billion in 2024, is expected to rise to $16.59 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.0%. The surging growth during the past period is believed to be due to initiatives that raise disease awareness, a trend in consumer consumption favoring natural and organic pet food, an increased rate of pet ownership worldwide, alterations in the regulation of veterinary pharmaceuticals, and an intensified consciousness about the health and nutrition of pets.

What's the Projected Size of the Global Veterinary Renal Disease Market by 2029?
Strong expansion is anticipated in the veterinary renal disease market in the upcoming years, with it expected to grow to $21.31 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. This anticipated growth during the forecast period is due to various factors such as the rise of personalized veterinary medicine, the growth of telemedicine and remote patient monitoring in the field of veterinary care, the increase in veterinary clinical trials and research, the use of blockchain for greater transparency in the supply chain of veterinary products, and the application of artificial intelligence and machine learning in veterinary diagnosis. Key trends during this forecast period encompass growth in demand for veterinary teleconsultations, an increase in bespoke nutrition plans for pets, the rise of pet health monitoring via wearable devices, expansion of telemedicine platforms in the veterinary field, and the utilization of precision medicine within veterinary oncology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Top Growth Drivers in the Veterinary Renal Disease Industry: What's Accelerating the Market?
The veterinary renal disease market is poised for growth, fueled by a rise in pet ownership. This market deals with conditions in animals that affect kidney function, potentially causing symptoms like increased thirst, constant urination, appetite loss, and weight reduction. Factors such as longer pet lives, exposure to environmental toxins, dietary influences, and inherited susceptibility contribute to its prevalence. Treatments for veterinary kidney diseases generally include dietary adjustments, medications, and fluid therapies to mitigate symptoms, slow the disease progression, and enhance the pet's life quality. Cooper Pet Care, a mobile pet care platform from the Netherlands, noted in October 2022 that approximately 145 million pets will reside in the European Union, incorporating Norway and Switzerland. This figure indicates a 5 million increment compared to 2021's pet population, approximated at 140 million. The animal count incorporates approximately 66 million dogs and 79 million cats. As a consequence, the surge in pet ownership is stimulating the expansion of the veterinary renal disease market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

What Trends Will Shape the Veterinary Renal Disease Market Through 2029 and Beyond?
Top corporations in the veterinary renal disease market are concentrating their efforts on technological advancements that can improve diagnostics and treatments. These advancements feature cutting-edge diagnostic tests capable of detecting kidney damage, even when there are no clear clinical symptoms. Such tests aim to spot minor shifts in renal functioning or structure, giving way to early interventions to prevent progression to severe kidney dysfunction. For instance, IDEXX Laboratories Inc., an American firm concentrating on the development and manufacturing of veterinary products, introduced the first-of-its-kind veterinary diagnostic tool for identifying kidney damage in cats and dogs in June 2023. Known as IDEXX Cystatin B Test, this tool assists veterinarians detect kidney damage before significant changes in kidney function become visible, thus improving patient outcomes. This test will be integrated into renal health assessment panels, offering vital insights during an estimated two million patient visits every year.

What Are the Main Segments in the Veterinary Renal Disease Market?
The veterinary renal disease market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels

Subsegments:
1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy
2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15957&type=smp

Which Top Companies are Driving Growth in the Veterinary Renal Disease Market?
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

Which Regions Will Dominate the Veterinary Renal Disease Market Through 2029?
North America was the largest region in the veterinary renal disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15957

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach out to us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

The Business Research Company, with over 17,500+ reports across 27 industries and 60+ geographies, backed by 1,500,000 datasets and insights from industry leaders, offers comprehensive market intelligence through its flagship product, the Global Market Model (GMM), delivering updated forecasts for informed decision-making.

This release was published on openPR.